Corcept Therapeutics Inc
XMUN:HTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corcept Therapeutics Inc
XMUN:HTD
|
US |
|
M
|
Mitsubishi Chemical Group Corp
XMUN:M3C
|
JP |
|
R
|
Richter Gedeon Vegyeszeti Gyar Nyrt
XMUN:RIG2
|
HU |
|
S
|
Schroders PLC
F:PYXA
|
UK |
|
P
|
Prosperity Investment Holdings Ltd
HKEX:310
|
HK |
|
Mauna Kea Technologies SA
F:1MK
|
FR |
Shareholder Yield
Current shareholder yield for 
HTD is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
HTD Price
Corcept Therapeutics Inc
| Average Annual Return | 40.67% |
| Standard Deviation of Annual Returns | 77.99% |
| Max Drawdown | -67% |
| Market Capitalization | 5.6B EUR |
| Shares Outstanding | 103 080 000 |
| Percentage of Shares Shorted |
N/A
|
